Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you sharpie.
Great video.
It is encouraging that there is/will be a lot of attention for naked shorting.
I suspect that our small company, with those fantastic results, can play a major role in this.
Trying to destroy a cure for cancer may and will soon be world news.
I think Ken is slowly starting to realize that he is going to be in serious trouble.
Trapped would be what Linda Powers would say.
GLTU
Malik brought in major investor Woodford and was given a place on the BOD at the time.
Pat Sarma brings in INDIA and gets a spot in the BOD.
mmmm similarity?
GLTU
Come on lefty.
The problem has been neatly resolved.
Everyone makes a mistake sometimes.
We really need you as a 'long' on the board.
All support for the NWBO cause is important and needed here.
We are already inundated with rubbish from real idiots here.
Best to you.
Thanks Captain.
GLTU
Thanks fluteman and Henry.
Not bad to have such an important patent granted in a country with 1.4 billion inhabitants.
GLTU
And Bio99 ofcourse :
Bio99
@BIO99_BIO99
Why you may wonder are cell and gene therapies being singled out for this type of approval? And does $NWBO fit into this? Absolutely!
1) They are advanced types of therapy that are complicated to develop, complicated to review and often done by small companies without the means to submit huge complicated submissions to numerous regulators at the same time.
2) Unlike traditional therapies, they are curative, and not for common simple diseases, but for devastating rarer diseases.
Thanks Peter.
Bio99
@BIO99_BIO99
Nineteen days after the $NWBO submission to the MHRA, the FDA without much fanfare announced an initiative that built on top of ORBIS called Cogent Global. It really went under the radar and I missed it and I haven't seen any $NWBO investor mentioning it. Why? Because it was (supposedly) for gene therapy. Nor did the FDA advertise it much. But read about it. It's for gene AND cell therapies. Its purpose is concurrent regulator review by everyone on novel gene [and cell therapies] for rare diseases [like GBM]. In other words, within days of the submission, all major regulators have had the setup to collaboratively examine the DCVax application for concurrent approval. Think about that. It's not even under the ORBIS name any more. Maybe I'm reading too much into it. But read it for yourself. https://natlawreview.com/article/fda-takes-first-step-toward-international-regulation-gene-therapies-treat-rare
Great post beachhyena.
And so TRUE!
GLTU.
Very sorry to read this Smokey21.
I wish you all the best.
GLTU
Thanks to Peter:
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) March 8, 2024
ARPA-H launches program to transform cancer care
Biden-Harris Administration announces revolutionary ARPA-H cancer treatment program poised to transform outcomes for Americans facing cancer
Published March 7, 2024
The ADAPT Program will transform cancer care… pic.twitter.com/5OZSOlxpEL
Thanks again Captain.
GLTU
Captain,
Thank you ilovetech.
GLTU
Thanks to Peter (pgsd) !
Post
See new posts
Conversation
Peter Davis
@peter_brit
#dcvax $nwbo #gbm
@TheLancet
Safe and effective cancer care: how long must we wait?
The Lancet Oncology
Published:March, 2024
DCVax® - personalized immune therapies for solid tumor cancers.
DCVax® - "The benign safety profile observed can enable treatment of patients vulnerable to adverse events. Furthermore, it avoids the need (and cost) for other treatments to manage side effects"
https://thelancet.com/journals/lanonc/article/PIIS1470-2045%2824%2900097-4/fulltext
I can smell your fear.
Ignore.
Flipper, what was the advantage of a 'STA' again?
I read it before but can't find the post.
Thanks in advance.
GLTU
Great news !
Thank you and Hoffmann for sharing.
GLTU
Well said bio.
Great post.
GLTU
Another one from Peter.
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) March 2, 2024
"Immuno-oncology (IO) represents a groundbreaking approach in cancer treatment. By harnessing the body’s own immune system to treat or eliminate cancer, IO may offer advantages over conventional anti-tumor agents"
"Looking ahead The continued discovery of new… pic.twitter.com/Z2VvazLBPl
Thanks Peter.
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) March 2, 2024
Immuno-oncology innovations redefining cancer treatment in 2024
In this exclusive interview, Dr Espen Basmo Ellingsen, a luminary in cancer immunology, provides insights into the anticipated breakthroughs, collaborative endeavours, and personalised strategies… pic.twitter.com/1pTX9GPcJO
Smokey,
If I'm not wrong, we are talking about 2 legs here.
One with DCvax + Poli-ICLC and the second with DCvax + Poly-ICLC+ Keytruda.
Just to see the added value of Keytruda.
GLTU
pffffffft.
Why should this be ' off topic'?
Thanks to Peter (pgsd).
#dcvax $nwbo #gbm #personalizedmedicine #precisiononcology
— Peter Davis (@peter_brit) March 1, 2024
DCVax® - personalized immune therapies for solid tumor cancers.
DCVax® - "The benign safety profile observed can enable treatment of patients vulnerable to adverse events. Furthermore, it avoids the need (and cost) for… https://t.co/vuLdLnvQB8
Chiugray,
Thanks Captain.
GLTU
Thanks for your response Chiugray.
This is the answer i hoped for.
My doubts were indeed about manual production for 1000 patients per month.
Cleanrooms are very necessary according to the data we had.
Thanks again and best to you.
Thanks for your response georgebaily.
As long as there is no real clarity from LP or Dr. Bosch, it remains a matter of speculation as to what the correct number per year is.
So not a fact.
GLTU
Chiugray,
Question: There has been a discussion based on the Hyperopia piece about the press release regarding Flaskwork.
This was about the number of batches that can be produced per year.
First manually and then a factor of 12 with flaskworks instead of manual.
My specific question is whether Dr. Bosch, when he talks about the scaling up of Sawston to 1000 patients per month, really meant the manual method.
Because then we are indeed talking about 144 k patients per year.
And then I don't take into account the simple expansion of the Eden systems, which of course take up much less space and also require less qualitative space to install many units.
After official approval ofcourse.
Thanks in advance for an answer.
GLTU
Great post Doc, thank you,
Fully agree.
GLTU
Thank you Follower.
Interesting piece.
I like this part :
Bio99
@BIO99_BIO99
On October 17th 2023, a new milestone was reached by the UK. It marked the first time ever that any treatment was both approved by the MHRA and authorized by NICE on the same day. NICE has been moving faster and faster to authorize treatments, particularly in cancer. In 2016 they were at 17 months post-approval for cancer treatments on average. By 2021 they had reached 1.8 months on average (and that was for the final input). Four months ago they had the first case of 0.0 months. Why did they move so fast? Because as they stated, it was for an aggressive cancer for which the new treatment sometimes put patients in permanent remission... Sounds like $NWBO DCVax, no? Which the MHRA is evaluating now too for the most aggressive cancer with otherwise zero long-term survival but which DCVax cures a large proportion of which... Something to think about...
Absolutely correct beartrap!
I agree with you 100%.
Furthermore, I am convinced that Linda has some surprises in store for us (and bashie!)
GLTU
The trade in nevercure has been halted.
Looks very strange.
Net loss increased in 4th quarter and the price shot up at the opening.
Manipulation the other way imo
https://finance.yahoo.com/news/novocure-ltd-nvcr-reports-mixed-123632878.html
d_stock reposted
Bio99
@BIO99_BIO99
Today the FDA approved Teclistemab for Relapsed/Refractory Multiple Myeloma based on real world data… now you might know why $NWBO is focused on obtaining real world data in UK compassionate cases of all types of cancer… including the most advanced and lethal ones… eventually regulators will bite… well beyond primary brain tumors…
As always Captain.
Thanks.
GLTU